Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

Continuous Glucose Monitoring System: Accuracy and Prognostic Value in Critically Ill Patients

Whether diabetic or non-diabetic patients, blood glucose management during ICU hospitalization is essential. This study aims to evaluate the accuracy of the iCan Continuous Glucose Monitoring (CGM) System for detecting blood glucose levels in ICU patients, as well as its value in prognostic evaluation, to provide reference for blood glucose management in critically ill patients.

Inclusion Criteria:

1. Age ≥ 18 years; gender not limited.
2. Expected ICU (Intensive Care Unit) stay ≥ 48 hours.
3. Patients requiring frequent blood gas monitoring in the ICU.

Exclusion Criteria:

1. The patient or their family refuses to use CGM for blood glucose monitoring.
2. Patients with adverse skin conditions (such as rash, active inflammation, etc.) in the device placement area, or those requiring emergency surgical intervention in that area.
3. Patients who need to undergo computed tomography (CT), X-ray, or magnetic resonance imaging (MRI) scans on the device placement area during the study period.